Talk:Center for Biologics Evaluation and Research

From Wikipedia, the free encyclopedia

WikiProject Medicine This article is within the scope of WikiProject Medicine. Please visit the project page for details or ask questions at the doctor's mess.
Start This page has been rated as Start-Class on the quality assessment scale
Low This article has been rated as Low-importance on the importance assessment scale
Center for Biologics Evaluation and Research is part of WikiProject Pharmacology, a project to improve all Pharmacology-related articles. If you would like to help improve this and other pharmacology articles, please join the project. All interested editors are welcome.
Start This article has been rated as Start-Class on the quality scale.

[edit] Needs more information

This article obviously needs more information. I'll start by adding a descriptive overview of CBER's roles and responsibilities. Other subtopics that I think should be included are:

  • History
  • Legislative authority
  • Products regulated
    • Blood products
    • Vaccines
    • Human tissues for transplantation
    • Allergenics and antitoxins
  • Application and review process
  • Recalls
  • Recent initiatives

This is probably not a complete list - I'm just brainstorming. --MEGaMark 15:39, 15 July 2006 (UTC)